Methods in Cancer Research, Volume 17Harris Busch |
Contents
VOLUME VI | 5 |
CHAPTER I | 6 |
Optimal Scheduling of Therapeutically Synergistic Drug Combinations | 39 |
Copyright | |
39 other sections not shown
Other editions - View all
Common terms and phrases
Actinomycin activity adriamycin alkylating agents anguidine animals anticancer drugs antimetabolite antineoplastic Ara-C bleomycin Cancer Chemother cancer chemotherapy Cancer Philadelphia Cancer Res carcinoma cellular chemotherapeutic combination chemotherapy COMPLETE CURES CPA A1 CR rates cure volume curve cyclophosphamide Daunomycin DAYS PERCENT DAYS POSTIMPLANT disease drug treatment effective evaluation excretion experimental exponential growth Frei Freireich Gompertzian growth and regression human tumors individual tumor L-PAM leukemia levels Lewis lung LIMIT OF PALPATION M. D. Anderson Hospital MeCCNU MEDIAN LIFE SPAN metabolism methotrexate MG/KG Mitomycin murine neoplastic nitrosoureas number of patients observed osteogenic sarcoma PALPATION MEDIAN pharmacokinetic pharmacologic phenomenological model plasma PR rates prednisone Procarbazine randomized clinical trial RANGE OF DEATHS rate of regression remission response rate Schabel schedule shark species studies Therapeutic synergism therapy tion tissues toxicity tumor cells tumor growth TUMOR REGRESSION 50 tumor response tumor volume TUMOR WEIGHT MG vincristine